Our results revealed the decrease of plasma LDL-C was in agreement with the up-regulation of LDLR, which suggests APS may regulate cholesterol homeostasis partially through inducing LDL-R expression. This evidence concerns the gene LDLR and autoimmune polyendocrinopathy.